OptiBP recording close up

Biospectal Raises $4.3M Seed Funding Led by Digital Health Investor, SeedLink

Today we are happy to announce the closing of a CHF 4.0M($4.3M) round of seed funding led by digital health investor, SeedLink, with additional funding from LabCorp,  Athensmed, Swiss based Privilege Ventures and other European and US investors. Biospectal will leverage the new funds to scale its OptiBP™ smartphone blood pressure monitoring application and data platform technology worldwide.

The funding we’ve received will accelerate Biospectal’s growth trajectory along with the appointments of Silicon Valley-based, interventional cardiologist and influential serial healthcare innovator, Dr. Fred St. Goar, MD, Tim Juergens, General Manager and co-founder of SeedLink, William Hanlon from LabCorp and Kustaa Piha, successful Health Tech Entrepreneur and Investor from Athensmed to the Biospectal Board of Directors.

Full press releases can be found here:
English
French
German

5 Blood Pressure Facts on World Hypertension Day 2021

This year on World Hypertension Day, the theme is “Measure Your Blood Pressure Accurately, Control It, Live Longer.” More than one billion people around the world live with hypertension (high blood pressure), putting them at risk of avoidable medical complications and death. 

 

We believe the answer is more frequent and meaningful monitoring. The United Nations has set a global goal for 2025 for a 25% reduction in uncontrolled hypertension. Awareness and diagnosis are the simple, yet crucial, answer to the global hypertension crisis. Increasing early control has become even more important in light of the COVID-19 pandemic, as heart conditions can make you more likely to become severely ill.   

 

In raising awareness, it’s important to know: 

1. The modern blood pressure cuff has been around for more than 100 years.

That’s right! For more than 100 years we’ve been measuring this vital health statistic the same way. Invented by Samuel Siegfried Karl Ritter von Basch in 1881, the modern blood pressure cuff, or sphygmomanometer, was popularized by Dr. Harvey Cushing in 1901. He brought the device to the US, modernized it and popularized it within the medical community. We definitely think it’s time to move past the traditional cuff!

 

2. Normal blood pressure range has changed. 

In 2017, The American Heart Association and American College of Cardiology redefined blood pressure guidelines, changing stage 1 levels from 140/90 to 130/80 mm Hg. At the time, the update meant that 30 million, or 14%, more American Adults officially had high blood pressure. 

 

3. Most people with high blood pressure do not know they have it. 

The biggest problem with hypertension – aka “the silent killer” – is there are no outward  symptoms, making it difficult and inconvenient to regularly measure and thus preventing proper management. Of the 1.13 billion people worldwide who have hypertension, only half have it under control

 

4. Young people and pregnant women can have hypertension, too. 

While high blood pressure is very common in older people due to aging vascular systems, they are not the only age group at risk. Nearly 1 in 4 adults aged 20 to 44 in the US, have high blood pressure, and according to CDC, high blood pressure happens in 1 in every 12 to 17 pregnancies among women ages 20 to 44.


5. Hypertension contributes to more than 1000 deaths per day. 

In the US, high blood pressure was a primary or contributing cause of death for more than 494,873 people in 2018. Having hypertension puts you at risk for heart disease and stroke, which are leading causes of death in the United States.

 

While there is no way to prevent primary hypertension, it can be controlled through a healthy lifestyle and medication if necessary, as advised by your doctor. Checking your blood pressure regularly is the only way to know for sure whether it is too high. Biospectal believes people need an easy to use, digital means to accurately measure, monitor, manage and share their blood pressure data with their doctors. Our OptiBP smartphone app and platform are the next step in advancing blood pressure monitoring using our breakthrough non-invasive optical biosensing algorithms. With the simple touch of a finger, OptiBP uses your smartphone’s camera to measure blood flow through the skin by simply applying your fingertip to the camera’s lens — in about 20 seconds — and without the inconvenience and discomfort of a traditional cuff. Anyone with a smartphone can measure their blood pressure – anywhere, anytime. See Biospectal OptiBP in action here.  


We are looking for users to help us test our revolutionary smartphone blood pressure solution. If you would like to become an OptiBP™ beta user, click here.

Biospectal medical study patient with OptiBP recording on smartphone.

Biospectal’s OptiBP Smartphone Software Achieves Blood Pressure Cuff Accuracy in Breakthrough Study Published in Scientific Reports in Nature

Scientific Reports in Nature logo

Scientific Reports in Nature has published the breakthrough results of our in depth research conducted at the University of Lausanne, Switzerland’s CHUV hospital by Professor Patrick Schoettker.

Focusing on optical blood pressure sensing using only the fingertip on a smartphone camera, the study demonstrated that our OptiBP™ software has achieved equivalency with the traditional blood pressure cuff performance and the ISO 81060-2 standard, representing no less than a revolution in how we measure and manage high blood pressure.

In the new world of (now essential) remote patient monitoring, especially in light of the Covid-19 pandemic, Biospectal’s OptiBP™ smartphone app and connected data platform enable clinical grade blood pressure management at the “point of patient” without any bulky extra device. 

Biospectal Blood Pressure Study Publication in Scientific Reports in Nature.

OptiBP™ enables better patient driven tracking of blood pressure and integration with the standard of care. Our real goal is improved health, length, and quality of life. With our software solution, anyone worldwide with a smartphone nearly instantly can now have a connected, smart, clinical grade monitor in the time it takes to download and install an app.

The Research Study can be downloaded below and accessed online at https://lnkd.in/gKZpGxK.

The study in PDF format can be downloaded here.

Biospectal Recognized as Top Remote Patient Monitoring Startup by High Tech Connect at International E-Healthcare Applications Summit

Our Biospectal team had a great day today being selected as runner up out of 160 contestants as a top startup innovator in remote patient monitoring at High Tech Connect’s International E-Healthcare Applications Summit in Winterthur, Switzerland! With the event’s theme of discovering “world-leading digital health technologies and hospital use cases,” we clearly showed that remote patient monitoring, such as our blood pressure solution, is no longer the future but a necessity in today’s world, especially when Covid-19 demands a shift to clinical monitoring at the Point of Patient.

Biospectal Chosen as One of Three Top Swiss Healthcare Startups for SHS Healthcare Madness


We’re at it again! Come visit us in Lausanne, Switzerland on 16 May where Biospectal will present as one of three top innovators by Swiss Healthcare Startups. We’ll present to a select group at SHS Healthcare Madness with Antoine Hubert (Swiss Medical Network) and Nicolas Durand (Abionic) in attendance. For details, see: https://swisshealthcarestartups.com/en/events/shs-healthcare-madness.

Biospectal at CES 2018

Biospectal One of Six Swiss Startups at CES 2018

CES Logo

Biospectal was honored to be chosen as one of six Swiss startups representing the next generation of Swiss innovation at this year’s CES in LasVegas. Dr. Patrick Schoettker was blown away by the interest in optical biosensing and Biospectal’s smartphone app solution for monitoring blood pressure through the fingertip.”We know that 1.4 Billion people in the world suffer from hypertension and that it’s obviously top of mind for much of the world’s population, but the interest was way beyond what we expected. Of course, our mission is to make a global impact on ‘the silent killer’ as WHO calls it, and CES was a huge validation that we’re on the right track with our proposition of making blood pressure measurement as available as Twitter, Facebook, or eBay – it’s another app on that phone in the pocket of any patient, clinician, or public health worker around the globe.”

“As such, we are intent on taking advantage of benefits of the existing smartphone user base to making a global impact through massive, friction free distribution of our technology. The traditional method of monitoring blood pressure, the brachial cuff, suffers from difficulty in distributing the devices, damage and breakage during use, inconvenience of having to maintain a separate device and discomfort and inconvenient patient experience. At Biospectal we’re working on solving all of those problems.”

Dr. Schoettker continues, “Most importantly, however, we’re hyper focused on making everything we do medical grade and adhering to the state of the art in terms of accuracy and reliability. We are, in short, intent on being a real solution as that brings serious new technology innovation to bear on improving world health.”

Founded in Switzerland with a global reach, Biospectal is currently working on several global health initiatives to begin rollout of their software platform

For more information, contact [email protected].

Related Press:

CE Today
6 Schweizer Start-ups an der CES vertreten

“>SaveSave

SaveSaveSaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave